An updated meta-analysis of methylenetetrahydrofolate reductase gene 677C/T polymorphism with diabetic nephropathy and diabetic retinopathy

Diabetes Research and Clinical Practice

Volumn 95, Issue 1, 2012, Pages 110-118

  Niu, Wenquan ^a   Qi, Yue ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Diabetic retinopathy; Meta analysis; Methylenetetrahydrofolate reductase; Polymorphism

Indexed keywords

ARTICLE; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; ETHNICITY; GENE; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; PROBABILITY; PUBLISHING; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SYSTEMATIC REVIEW;

DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84355166568     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.10.009     Document Type: Article

References (49)

1. [last accessed 15.08.11]. http://www.who.int/diabetes/.
2. Resnikoff S., Pascolini D., Etya'ale D., Kocur I., Pararajasegaram R., Pokharel G.P., et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004, 82:844-851.
3. Pettitt D.J., Saad M.F., Bennett P.H., Nelson R.G., Knowler W.C. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990, 33:438-443.
4. Borch-Johnsen K., Nørgaard K., Hommel E., Mathiesen E.R., Jensen J.S., Deckert T., et al. Is diabetic nephropathy an inherited complication?. Kidney Int 1992, 41:719-722.
5. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997, 46:1829-1839.
6. Agius E., Attard G., Shakespeare L., Clark P., Vidya M.A., Hattersley A.T., et al. Familial factors in diabetic nephropathy: an offspring study. Diabet Med 2006, 23:331-334.
7. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998, 338:1042-1050.
8. D'Angelo A., Selhub J. Homocysteine and thrombotic disease. Blood 1997, 90:1-11.
9. Engbersen A.M., Franken D.G., Boers G.H., Stevens E.M., Trijbels F.J., Blom H.J. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995, 56:142-150.
10. Friedman G., Goldschmidt N., Friedlander Y., Ben-Yehuda A., Selhub J., Babaey S., et al. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 1999, 129:1656-1661.
11. Niu W., Qi Y. Association of α-adducin and G-protein β3 genetic polymorphisms with hypertension: a meta-analysis of Chinese populations. PLoS One 2011, 6:e17052.
12. Borenstein M., Hedges L.V., Higgins J.P.T., Rothstein H.R. Introduction to Meta-Analysis 2009, John Wiley & Sons, Ltd.
13. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Br Med J 2003, 327:557-560.
14. Neugebauer S., Baba T., Watanabe T. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients. Lancet 1998, 352:454.
15. Shcherbak N.S., Shutskaya Z.V., Sheidina A.M., Larionova V.I., Schwartz E.I. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients. Mol Genet Metab 1999, 68:375-378.
16. Fujita H., Narita T., Meguro H., Ishii T., Hanyu O., Suzuki K., et al. No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type II diabetic patients with proliferative diabetic retinopathy. J Diabetes Complications 1999, 13:284-287.
17. Blüthner M., Brüntgens A., Schmidt S., Strojek K., Grzeszczak W., Ritz E. Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes?. Nephrol Dial Transplant 1999, 14:56-57.
18. Smyth J.S., Savage D.A., Maxwell A.P. MTHFR gene polymorphism and diabetic nephropathy in type 1 diabetes. Lancet 1999, 353:1156-1157.
19. Odawara M., Yamashita K. A common mutation of the methylenetetrahydrofolate reductase gene as a risk factor for diabetic nephropathy. Diabetologia 1999, 42:631-632.
20. Shpichinetsky V., Raz I., Friedlander Y., Goldschmidt N., Wexler I.D., Ben-Yehuda A., et al. The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. J Nutr 2000, 130:2493-2497.
21. Makita Y., Moczulski D.K., Bochenski J., Smiles A.M., Warram J.H., Krolewski A.S. Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes. Am J Kidney Dis 2003, 41:1189-1194.
22. Moczulski D., Fojcik H., Zukowska-Szczechowska E., Szydlowska I., Grzeszczak W. Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol Dial Transplant 2003, 18:1535-1540.
23. Sun J., Xu Y., Zhu Y., Lu H. Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 2004, 64:185-190.
24. Ksiazek P., Bednarek-Skublewska A., Buraczyńska M. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus. Med Sci Monit 2004, 10:BR47-BR51.
25. Yoshioka K., Yoshida T., Umekawa T., Kogure A., Takakura Y., Toda H., et al. Methylenetetrahydrofolate reductase gene polymorphism is not related to diabetic nephropathy in Japanese type 2 diabetic patients. Diabet Med 2004, 21:1051-1052.
26. Mtiraoui N., Ezzidi I., Chaieb M., Marmouche H., Aouni Z., Chaieb A., et al. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract 2007, 75:99-106.
27. Böger C.A., Stubanus M., Haak T., Götz A.K., Christ J., Hoffmann U., et al. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy. Nephrol Dial Transplant 2007, 22:154-162.
28. Rahimi M., Hasanvand A., Rahimi Z., Vaisi-Raygani A., Mozafari H., Rezaei M., et al. Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus. Clin Biochem 2010, 43:1333-1339.
29. Nemr R., Salman R.A., Jawad L.H., Juma E.A., Keleshian S.H., Almawi W.Y. Differential contribution of MTHFR C677T variant to the risk of diabetic nephropathy in Lebanese and Bahraini Arabs. Clin Chem Lab Med 2010, 48:1091-1094.
30. Ukinc K., Ersoz H.O., Karahan C., Erem C., Eminagaoglu S., Hacihasanoglu A.B., et al. Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine 2009, 36:255-261.
31. Eroglu Z., Erdogan M., Tetik A., Karadeniz M., Cetinalp S., Kosova B., et al. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy. Diabetes Metab Res Rev 2007, 23:621-624.
32. Movva S., Alluri R.V., Venkatasubramanian S., Vedicherla B., Vattam K.K., Ahuja Y.R., et al. Association of methylene tetrahydrofolate reductase C677T genotype with type 2 diabetes mellitus patients with and without renal complications. Genet Test Mol Biomarkers 2011, 15:257-261.
33. Maeda M., Yamamoto I., Fukuda M., Motomura T., Nishida M., Nonen S., et al. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients. J Diabetes Complications 2008, 22:119-125.
34. Wang L., Wang J., Xue Y., Chen Y., Zou H. Relationship between methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2001, 18:276-278.
35. Errera F.I., Silva M.E., Yeh E., Maranduba C.M., Folco B., Takahashi W., et al. Effect of polymorphisms of the MTHFR and APOE genes on susceptibility to diabetes and severity of diabetic retinopathy in Brazilian patients. Braz J Med Biol Res 2006, 39:883-888.
36. Neugebauer S., Baba T., Kurokawa K., Watanabe T. Defective homocysteine metabolism as a risk factor for diabetic retinopathy. Lancet 1997, 349:473-474.
37. Santos K.G., Tschiedel B., Schneider J., Souto K., Roisenberg I. Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: relationship with polymorphisms in the aldose reductase the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes. Diabetes Res Clin Pract 2003, 61:133-136.
38. Sun J., Xu Y., Zhu Y., Lu H., Deng H., Fan Y., et al. The relationship between MTHFR gene polymorphisms plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus. Chin Med J (Engl) 2003, 116:145-147.
39. Yoshioka K., Yoshida T., Takakura Y., Kogure A., Umekawa T., Toda H., et al. No association between the MTHFR gene polymorphism and diabetic retinopathy in type 2 diabetic patients without overt nephropathy. Diabetes Care 2003, 26:1947-1948.
40. Maeda M., Yamamoto I., Fukuda M., Nishida M., Fujitsu J., Nonen S., et al. MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation. Diabetes Care 2003, 26:547-548.
41. Zintzaras E., Chatzoulis D.Z., Karabatsas C.H., Stefanidis I. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet 2005, 50:267-275.
42. Zintzaras E., Uhlig K., Koukoulis G.N., Papathanasiou A.A., Stefanidis I. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J Hum Genet 2007, 52:881-890.
43. Abhary S., Hewitt A.W., Burdon K.P., Craig J.E. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes 2009, 58:2137-2147.
44. Mooyaart A.L., Valk E.J., van Es L.A., Bruijn J.A., de Heer E., Freedman B.I., et al. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia 2011, 54:544-553.
45. Benes P., Kanková K., Muzík J., Groch L., Benedík J., Elbl L., et al. Methylenetetrahydrofolate reductase polymorphism type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population. Mol Genet Metab 2001, 73:188-195.
46. Mooyaart A.L., Zutinic A., Bakker S.J., Grootendorst D.C., Kleefstra N., van Valkengoed I.G., et al. Association between CNDP1 genotype and diabetic nephropathy is sex specific. Diabetes 2010, 59:1555-1559.
47. Young B.A., Pugh J.A., Maynard C., Reiber G. Diabetes and renal disease in veterans. Diabetes Care 2004, 27:B45-B49.
48. Fatehi A.N., Bevers M.M., Schoevers E., Roelen B.A., Colenbrander B., Gadella B.M. DNA damage in bovine sperm does not block fertilization and early embryonic development but induces apoptosis after the first cleavages. J Androl 2006, 27:176-188.
49. Gale E.A. How to survive diabetes. Diabetologia 2009, 52:559-567.